Literature DB >> 17562775

Conserved regions from Neisseria gonorrhoeae pilin are immunosilent and not immunosuppressive.

Johanna K Hansen1, Karen P Demick, John M Mansfield, Katrina T Forest.   

Abstract

PilE is the primary subunit of type IV pili from Neisseria gonorrhoeae and contains a surface-exposed hypervariable region thought to be one feature of pili that has prevented development of a pilin-based vaccine. We have created a three-dimensional structure-based antigen by replacing the hypervariable region of PilE with an aspartate-glutamine linker chosen from the sequence of Pseudomonas aeruginosa PilA. We then characterized murine immune responses to this novel protein to determine if conserved PilE regions could serve as a vaccine candidate. The control PilE protein elicited strong T-cell-dependent B-cell responses that are specific to epitopes in both the hypervariable deletion and control proteins. In contrast, the hypervariable deletion protein was unable to elicit an immune response in mice, suggesting that in the absence of the hypervariable region, the conserved regions of PilE alone are not sufficient for antibody production. Further analysis of these PilE proteins with suppressor cell assays showed that neither suppresses T- or B-cell responses, and flow cytometry experiments suggested that they do not exert suppressor effects by activating T regulatory cells. Our results show that in the murine model, the hypervariable region of PilE is required to activate immune responses to pilin, whereas the conserved regions are unusually nonimmunogenic. In addition, we show that both hypervariable and conserved regions of pilin are not suppressive, suggesting that PilE does not cause the decrease in T-cell populations observed during gonococcal cervicitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17562775      PMCID: PMC1951979          DOI: 10.1128/IAI.02015-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  55 in total

1.  Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction.

Authors:  R M Horton; Z L Cai; S N Ho; L R Pease
Journal:  Biotechniques       Date:  1990-05       Impact factor: 1.993

2.  Lymphocyte function in experimental African trypanosomiasis. II. Splenic suppressor cell activity.

Authors:  S R Wellhausen; J M Mansfield
Journal:  J Immunol       Date:  1979-03       Impact factor: 5.422

3.  Rates in vitro changes of gonococcal colony opacity phenotypes.

Authors:  L W Mayer
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

4.  Role of chromosomal rearrangement in N. gonorrhoeae pilus phase variation.

Authors:  E Segal; E Billyard; M So; S Storzbach; T F Meyer
Journal:  Cell       Date:  1985-02       Impact factor: 41.582

5.  Efficacy trial of a parenteral gonococcal pilus vaccine in men.

Authors:  J W Boslego; E C Tramont; R C Chung; D G McChesney; J Ciak; J C Sadoff; M V Piziak; J D Brown; C C Brinton; S W Wood
Journal:  Vaccine       Date:  1991-03       Impact factor: 3.641

6.  Thyroiditis in T cell-depleted rats: suppression of the autoallergic response by reconstitution with normal lymphoid cells.

Authors:  W J Penhale; W J Irvine; J R Inglis; A Farmer
Journal:  Clin Exp Immunol       Date:  1976-07       Impact factor: 4.330

7.  Reassessment of Ellman's reagent.

Authors:  P W Riddles; R L Blakeley; B Zerner
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

8.  Neisseria gonorrhoeae kills carcinoembryonic antigen-related cellular adhesion molecule 1 (CD66a)-expressing human B cells and inhibits antibody production.

Authors:  Milica Pantelic; Young-June Kim; Silvia Bolland; Ines Chen; John Shively; Tie Chen
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

9.  Antigenic variation of pilin regulates adhesion of Neisseria meningitidis to human epithelial cells.

Authors:  X Nassif; J Lowy; P Stenberg; P O'Gaora; A Ganji; M So
Journal:  Mol Microbiol       Date:  1993-05       Impact factor: 3.501

10.  A real-time semi-quantitative RT-PCR assay demonstrates that the pilE sequence dictates the frequency and characteristics of pilin antigenic variation in Neisseria gonorrhoeae.

Authors:  Melissa S Rohrer; Matthew P Lazio; H Steven Seifert
Journal:  Nucleic Acids Res       Date:  2005-06-09       Impact factor: 16.971

View more
  6 in total

1.  Beyond the Crystal Structure: Insight into the Function and Vaccine Potential of TbpA Expressed by Neisseria gonorrhoeae.

Authors:  Devin R Cash; Nicholas Noinaj; Susan K Buchanan; Cynthia Nau Cornelissen
Journal:  Infect Immun       Date:  2015-09-08       Impact factor: 3.441

Review 2.  Identification and characterization of gonococcal iron transport systems as potential vaccine antigens.

Authors:  C N Cornelissen
Journal:  Future Microbiol       Date:  2008-06       Impact factor: 3.165

3.  Structure of the Vibrio cholerae Type IVb Pilus and stability comparison with the Neisseria gonorrhoeae type IVa pilus.

Authors:  Juliana Li; Edward H Egelman; Lisa Craig
Journal:  J Mol Biol       Date:  2012-02-21       Impact factor: 5.469

4.  Neisseria gonorrhoeae enhances HIV-1 infection of primary resting CD4+ T cells through TLR2 activation.

Authors:  Jian Ding; Aprille Rapista; Natalia Teleshova; Goar Mosoyan; Gary A Jarvis; Mary E Klotman; Theresa L Chang
Journal:  J Immunol       Date:  2010-02-10       Impact factor: 5.422

5.  Antibodies with higher bactericidal activity induced by a Neisseria gonorrhoeae Rmp deletion mutant strain.

Authors:  Guocai Li; Rushan Xie; Xiaoping Zhu; Yanli Mao; Shuangxi Liu; Hongmei Jiao; Hua Yan; Kun Xiong; Mingchun Ji
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

6.  Evaluation of the Diagnostic Efficacy of Xpert CT/NG for Chlamydia trachomatis and Neisseria gonorrhoeae.

Authors:  Tian-Ao Xie; Ye-Ling Liu; Rui-Chun Meng; Xiao-Shan Liu; Ke-Ying Fang; Shu-Ting Deng; Shu-Jin Fan; Chu-Mao Chen; Qin-Rong Lin; Zhi-Jian He; Zhen-Xing Li; Shi Ouyang; Guo-Dong Zhu; Tian-Xing Ji; Yong Xia; Zhi-Yong Pan; Xu-Guang Guo
Journal:  Biomed Res Int       Date:  2020-10-08       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.